Thank you for making TIDES 2013 a success!

The 15th Anniversary TIDES 2013 conference gave 800 attendees the chance to get up to speed with oligonucleotide and peptide manufacturing, oligonucleotide therapeutics discovery, peptide discovery and development and nucleic acids technologies for molecular diagnostics. In addition - numerous networking opportunities allowed attendees to meet with exhibitors, poster presenters, speakers and peers.

Mark Your Calendar

TIDES 2014
May 12-15, 2014
Rhode Island Convention Center
Providence, Rhode Island

• Read the posts from TIDES 2013 on Twitter
• See who attended
• View the poster list
• View the onsite event guide

The TIDES Summit Features 5 Tracks that Cover the Full Spectrum of Advances in Oligonucleotide and Peptide Discovery, Development and Manufacturing... What’s Your Focus?

Keynote Presentations

Mipomersen Clinical Advances	Epitope Targeting PCC Agents	Spherical Nucleic Acids (SNAS)	VC Funding for Oligos and Peptides	Delivery and Device Strategies for Peptides
Mary P. McGowan, M.D.Senior Medical Director, Clinical Research, Genzyme, A Sanofi Company	James R. Heath, Ph.D.Professor, Chemistry and Chemical Engineering, California Institute Of Technology	Chad A. Mirkin, Ph.D.Professor, Chemistry, Northwestern University	Bruce Booth, D.Phil.Partner, Life Sciences, Atlas Venture	William J. Lambert, Ph.D.Fellow, Drug Delivery and Device Development, Medimmune, Inc.

Oligonucleotide Manufacturing, Technology and Product Development

• Hear first-hand reviews from regulatory and industry thought leaders on quality and purity specifications to answer your pressing questions about impurities specifications
• Implement continued process verification with latest perspective of industry consortium
• Modernize your process science with cutting-edge reports in the new process chemistry session

Peptide Manufacturing, Technology and Product Development

• FDA perspective and scale up report on peptide vaccines
• Plan for the future of novel synthesis technologies with new data from Lonza, Bachem and EMD
• Learn how to assess and prevent aggregation to avoid late stage problems that can hold up product release

Oligonucleotide Therapeutics Discovery

• Discover new developments in single stranded RNAs, non-coding RNAs and non-hepatic cell and tissue targeting
• Find out what it really takes to bring an oligonucleotide drug to market and learn about the phase-specific strategies you should be implementing
• Explore emerging solutions to the oligonucleotide delivery challenge and hear the latest preclinical and clinical data to inform your own oligonucleotide therapeutic projects

Peptide Discovery and Development

• Discover the latest advances in peptide-like scaffolds and structures and peptides as protein-protein interaction modulators to accelerate your discovery efforts
• Hear new preclinical and clinical data from multiple peptide drugs in development to provide you lessons for your own projects
• Find novel synthetic approaches to modify peptides and strategies for intracellular peptide delivery to improve the drug-like properties of your molecules

Nucleic Acids Technologies for Molecular Diagnostics

• Learn new technologies for sample prep and for the diagnostics of the future
• Ensure supply chain for labels and modifications to avoid interruptions in distribution

The Industry's Premier Scientific, Business and Networking Event

Learn, network and collaborate with over 750 delegates and more than 90 technology and service providers.

• Hear directly from international regulatory agencies in presentations and break-out discussions including CBER, FDA and the Swedish Medical Products Agency
• Gain the latest data on CMC manufacturing, conjugation strategies, formulation and delivery, and cutting edge discovery breakthroughs from all the major players plus the latest emerging biotechs.

"TIDES is THE venue for oligonucleotides and peptides together. The complete package only exists in one setting and that's TIDES. There is no forum that has the same level of expertise in one place at one time other than TIDES." - Scott Petersen, Ph.D., Chief Scientific Officer, Liposciences, Inc.